[HTML][HTML] Inflammatory mediators of platelet activation: focus on atherosclerosis and COVID-19

P Theofilis, M Sagris, AS Antonopoulos… - International Journal of …, 2021 - mdpi.com
Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …

Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19

P Theofilis, M Sagris, AS Antonopoulos, E Oikonomou… - 2021 - agris.fao.org
Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …

[PDF][PDF] Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19

P Theofilis, M Sagris, AS Antonopoulos… - Int. J. Mol …, 2021 - pdfs.semanticscholar.org
Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …

Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19

P Theofilis, M Sagris… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …

Inflammatory mediators of platelet activation: focus on atherosclerosis and COVID-19.

P Theofilis, M Sagris, AS Antonopoulos, E Oikonomou… - 2021 - cabidigitallibrary.org
Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …

Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19

P Theofilis, M Sagris, AS Antonopoulos… - International …, 2021 - search.proquest.com
Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …

[HTML][HTML] Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19

P Theofilis, M Sagris, AS Antonopoulos… - … Journal of Molecular …, 2021 - ncbi.nlm.nih.gov
Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …

Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19.

P Theofilis, M Sagris, AS Antonopoulos… - … Journal of Molecular …, 2021 - europepmc.org
Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …

Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19.

P Theofilis, M Sagris… - International …, 2021 - search.ebscohost.com
Background: Atherosclerotic cardiovascular diseases are characterized by a dysregulated
inflammatory and thrombotic state, leading to devastating complications with increased …